TGFb modulation of MIPla expression in human fetal microglia

C. M. McManus, Joan W. Berman

Research output: Contribution to journalArticle

Abstract

Microglial cells play an important regulatory role in inflammatory diseases of the central nervous system (CNS), such as multiple sclerosis. Monocyte chemoattractants have been shown to be expressed in the CNS of animal models of multiple sclerosis. As the regulation of these chemoattractants may be key to the progression of the neuroimmunologic diseases, we analyzed expression of MIPla in human fetal microglial cultures. The cells express minimal levels of MIPla, but when treated with LPS(10ng/ml) MIPla message and protein is induced in a dose and time dependent manner. Pretreatment of cultures with TGFb (10ng/ml) downmodulates this expression at both the message and protein level. Similarly, cotreatment with TGFb (10ng/ml) and LPS (10ng/ml) appears to reduce MIPla expression when compared to treatment with LPS alone. These results indicate that TGFb may function to decrease chemoattraction of inflammatory cells to the site of injury in neuroimmunologic diseases.

Original languageEnglish (US)
JournalFASEB Journal
Volume10
Issue number6
StatePublished - 1996

Fingerprint

neuroglia
Microglia
chemoattractants
Chemotactic Factors
Modulation
sclerosis
Neurology
Multiple Sclerosis
central nervous system diseases
Central Nervous System Diseases
cells
disease course
monocytes
central nervous system
Disease Progression
Monocytes
Animals
Proteins
Central Nervous System
Animal Models

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

TGFb modulation of MIPla expression in human fetal microglia. / McManus, C. M.; Berman, Joan W.

In: FASEB Journal, Vol. 10, No. 6, 1996.

Research output: Contribution to journalArticle

@article{3cfb67d01e6c4ad79805f34f0727f659,
title = "TGFb modulation of MIPla expression in human fetal microglia",
abstract = "Microglial cells play an important regulatory role in inflammatory diseases of the central nervous system (CNS), such as multiple sclerosis. Monocyte chemoattractants have been shown to be expressed in the CNS of animal models of multiple sclerosis. As the regulation of these chemoattractants may be key to the progression of the neuroimmunologic diseases, we analyzed expression of MIPla in human fetal microglial cultures. The cells express minimal levels of MIPla, but when treated with LPS(10ng/ml) MIPla message and protein is induced in a dose and time dependent manner. Pretreatment of cultures with TGFb (10ng/ml) downmodulates this expression at both the message and protein level. Similarly, cotreatment with TGFb (10ng/ml) and LPS (10ng/ml) appears to reduce MIPla expression when compared to treatment with LPS alone. These results indicate that TGFb may function to decrease chemoattraction of inflammatory cells to the site of injury in neuroimmunologic diseases.",
author = "McManus, {C. M.} and Berman, {Joan W.}",
year = "1996",
language = "English (US)",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - TGFb modulation of MIPla expression in human fetal microglia

AU - McManus, C. M.

AU - Berman, Joan W.

PY - 1996

Y1 - 1996

N2 - Microglial cells play an important regulatory role in inflammatory diseases of the central nervous system (CNS), such as multiple sclerosis. Monocyte chemoattractants have been shown to be expressed in the CNS of animal models of multiple sclerosis. As the regulation of these chemoattractants may be key to the progression of the neuroimmunologic diseases, we analyzed expression of MIPla in human fetal microglial cultures. The cells express minimal levels of MIPla, but when treated with LPS(10ng/ml) MIPla message and protein is induced in a dose and time dependent manner. Pretreatment of cultures with TGFb (10ng/ml) downmodulates this expression at both the message and protein level. Similarly, cotreatment with TGFb (10ng/ml) and LPS (10ng/ml) appears to reduce MIPla expression when compared to treatment with LPS alone. These results indicate that TGFb may function to decrease chemoattraction of inflammatory cells to the site of injury in neuroimmunologic diseases.

AB - Microglial cells play an important regulatory role in inflammatory diseases of the central nervous system (CNS), such as multiple sclerosis. Monocyte chemoattractants have been shown to be expressed in the CNS of animal models of multiple sclerosis. As the regulation of these chemoattractants may be key to the progression of the neuroimmunologic diseases, we analyzed expression of MIPla in human fetal microglial cultures. The cells express minimal levels of MIPla, but when treated with LPS(10ng/ml) MIPla message and protein is induced in a dose and time dependent manner. Pretreatment of cultures with TGFb (10ng/ml) downmodulates this expression at both the message and protein level. Similarly, cotreatment with TGFb (10ng/ml) and LPS (10ng/ml) appears to reduce MIPla expression when compared to treatment with LPS alone. These results indicate that TGFb may function to decrease chemoattraction of inflammatory cells to the site of injury in neuroimmunologic diseases.

UR - http://www.scopus.com/inward/record.url?scp=33749151625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749151625&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749151625

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 6

ER -